Managing inpatient hyperglycaemia and initiating sodium-glucose cotransporter 2 inhibitor therapy in the setting of diabetes and acute coronary syndrome

Sarah A Hitchen, Nick S R Lan, Adam L Hort, James M Rankin, P Gerry Fegan, Bu B Yeap

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

We previously showed that implementing algorithms for managing diabetes in acute coronary syndrome was associated with improved inpatient glycaemic control and increased sodium-glucose cotransporter 2 (SGLT2) inhibitor prescriptions. The present study performed 1 year later found that inpatient hyperglycaemia had relapsed to pre-intervention rates, although SGLT2 inhibitor prescriptions remained increased. We discuss the challenges of improving inpatient glycaemic control.

Original languageEnglish
Pages (from-to)428-432
Number of pages5
JournalInternal Medicine Journal
Volume51
Issue number3
DOIs
Publication statusPublished - Mar 2021

Fingerprint

Dive into the research topics of 'Managing inpatient hyperglycaemia and initiating sodium-glucose cotransporter 2 inhibitor therapy in the setting of diabetes and acute coronary syndrome'. Together they form a unique fingerprint.

Cite this